Connect with us

Hi, what are you looking for?

Business

DA Davidson Raises Arcosa Price Target to $120 Amid Earnings Report

Investment firm DA Davidson has increased its price target for Arcosa, Inc. (NYSE: ACA) from $110.00 to $120.00, according to a research report released on the morning of August 7, 2023. This adjustment comes as Arcosa reported stronger-than-expected earnings for the recent quarter, prompting DA Davidson to maintain a buy rating on the stock.

Arcosa shares opened at $95.77 on Monday, reflecting a slight decrease of 0.2% from the previous trading session. The company’s financial metrics indicate a debt-to-equity ratio of 0.67, a quick ratio of 1.35, and a current ratio of 2.12. Over the past year, the stock has fluctuated between a low of $68.11 and a high of $113.43, with a market capitalization currently standing at $4.68 billion.

Arcosa’s price-to-earnings ratio is reported at 50.94, and the stock has a beta of 1.01, indicating it moves in line with market trends. The company’s moving averages are noted at $88.34 for the 50-day period and $86.69 for the 200-day period, suggesting a positive outlook in the near term.

Quarterly Earnings Exceed Expectations

In its latest earnings report released on August 7, Arcosa announced earnings per share (EPS) of $1.27, surpassing analysts’ expectations of $1.05 by $0.22. Despite achieving a net margin of 3.45% and a return on equity of 6.25%, the company’s revenue for the quarter was $736.90 million, falling short of the anticipated $754.20 million. This represented a year-over-year revenue growth of 10.9%, compared to $0.91 EPS from the same quarter last year. Analysts forecast that Arcosa will report an EPS of 3.23 for the current fiscal year.

Insider Transactions and Institutional Holdings

In related developments, insider Kerry S. Cole sold 7,966 shares of Arcosa stock on August 11, 2023, at an average price of $95.77, resulting in a transaction value of $762,903.82. Following this sale, Cole holds 19,769 shares valued at approximately $1,893,277.13, marking a 28.72% reduction in ownership.

Similarly, insider Jesse E. Jr. Collins sold 8,616 shares on June 17, 2023, at an average price of $86.40, totaling $744,422.40. This sale reduced Collins’ stake by 40.70%. Over the last 90 days, insiders have sold a total of 17,417 shares worth approximately $1,581,282. Currently, insiders hold 1.20% of the company’s stock.

Institutional investors continue to play a significant role in Arcosa’s ownership. Recent activity includes Banque Cantonale Vaudoise acquiring a new stake valued at $28,000 in the first quarter, while Trust Co. of Toledo NA purchased shares worth $40,000 in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. also invested $51,000 during the same period. Currently, institutional investors own a substantial 90.66% of Arcosa’s stock.

Founded to provide infrastructure-related products and solutions for the construction, engineered structures, and transportation markets, Arcosa operates through three segments: Construction Products, Engineered Structures, and Transportation Products. The company’s robust performance and optimistic outlook, underscored by the recent price target adjustment, highlight its growing significance in the industry.

You May Also Like

Technology

Tesla (TSLA) recently reported a year-over-year drop in second-quarter deliveries, yet the market responded with optimism, pushing the stock up by 5%. This unexpected...

Health

The All England Lawn Tennis Club in London experienced its hottest-ever opening day on Monday, as the prestigious Wimbledon tournament kicked off under unprecedented...

Science

Look out, daters: a new toxic relationship trend is sweeping through the romantic world, leaving many baffled and heartbroken. Known as “Banksying,” this phenomenon...

Technology

In a bold reimagining of the DC Universe, director James Gunn has introduced a significant narrative element in his latest film, which reveals that...

Entertainment

Netflix’s eagerly anticipated talent competition Building the Band is set to premiere on July 9, promising an emotional journey for viewers. This series, centered...

Technology

Former Speaker of the House Nancy Pelosi has recently made headlines with her latest investment in the tech sector. According to official filings, she...

Entertainment

A new documentary series titled “Animals on Drugs” is set to premiere on the Discovery Channel on July 28, 2023. The three-part series follows...

World

The first dose of the hepatitis B vaccine is recommended at birth, a practice that has come under scrutiny following recent comments by Health...

Technology

The Evo 2025 tournament is set to take place from August 1 to August 3, 2025, showcasing some of the most popular fighting games...

Sports

ZAGREB, Croatia — A concert by Marko Perkovic, a right-wing Croatian singer known for his controversial views, attracted tens of thousands of fans to...

Politics

Billionaire hedge fund manager Bill Ackman faced significant backlash following his professional tennis debut at the Hall of Fame Open in Newport, Rhode Island,...

Business

Erin Dana Lichy, a prominent cast member of “Real Housewives of New York,” has officially settled into her dream home, a grand townhouse located...

Sports

As the summer of 2025 unfolds, the video game industry is set to deliver a diverse array of new releases that promise to captivate...

Lifestyle

The upcoming TRNSMT 2025 festival is set to take place from July 7 to July 9, 2025, at Glasgow Green, and organizers have released...

Entertainment

While the echoes of Summer Game Fest 2025 and the Xbox Games Showcase still resonate, Xbox has already set its sights on the next...

Technology

Meta has officially opened preorders for its new Oakley smart glasses, the limited edition HSTN, ahead of their anticipated release on July 22, 2023....

Copyright © All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site.